Login to Your Account



A-T, G-C . . . and more? Synthorx launched on new DNA base pair tech

By Michael Fitzhugh
Staff Writer

Thursday, May 8, 2014
Synthorx Inc., a new synthetic biology company backed by Avalon and Correlation Ventures, is leveraging exclusive rights to a technology for creating synthetic DNA base pairs to improve the discovery and development of new medicines, diagnostics and vaccines.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription